Skip to main content

Table 4 Awarded points for VTS score

From: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy

  0 points 0.5 points 1 point
Cumulative brain metastases volume > 1.5 cc < 1.5 cc  
Timing synchronous metachronous  
Systemic treatment targeted therapy   immunotherapy